Penn Medicine

Doylestown Hospital is a Bucks County-based community hospital that offers a range of healthcare services.

HealthShare Exchange is a healthcare data collector that offers health information exchange and population health monitor services.

TwentyEight Health, Inc. is a Brooklyn-based company focused on providing an online platform dedicated to women's reproductive and sexual health. Established in 2018, the platform offers online doctor evaluations for birth control prescriptions, facilitates quick home deliveries of medications, and enables secure messaging between women and their healthcare providers. By prioritizing underserved populations, particularly Medicaid recipients, TwentyEight Health aims to enhance access to high-quality and inclusive women's health services, thereby creating a digital healthcare home that emphasizes convenience and affordability in care.

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas. Intravenous in vivo CAR treatment, which treats B cell lymphomas, is the company's flagship program. Its unique engineering provides exceptional target tissue specificity. The business is working on a second initiative to address autoimmune conditions. With the help of Interius, a novel and distinct therapeutic modality for the precise administration of gene therapies may soon be made available to patients in expanded care settings, without the need for preconditioning chemotherapy.

Carisma Therapeutics is a clinical-stage biotechnology company dedicated to developing innovative immunotherapies for cancer and other serious diseases through its proprietary chimeric antigen receptor macrophage technology. The company focuses on engineering macrophages and monocytes, which are specialized white blood cells, to enhance their ability to infiltrate solid tumors and deliver potent cellular immunotherapy. By leveraging advanced cell engineering techniques, Carisma aims to provide effective treatments that enable patients with solid tumors to benefit from targeted and robust cancer therapies.

Carisma Therapeutics is a clinical-stage biotechnology company dedicated to developing innovative immunotherapies for cancer and other serious diseases through its proprietary chimeric antigen receptor macrophage technology. The company focuses on engineering macrophages and monocytes, which are specialized white blood cells, to enhance their ability to infiltrate solid tumors and deliver potent cellular immunotherapy. By leveraging advanced cell engineering techniques, Carisma aims to provide effective treatments that enable patients with solid tumors to benefit from targeted and robust cancer therapies.

Tissue Analytics, Inc. is a company that develops a mobile application designed to facilitate the measurement and analysis of chronic wounds, burns, and skin conditions. This innovative solution allows home health agencies, nursing homes, and medical practices to send patient photographs and perform wound analysis. The application automatically generates formatted patient reports and enables tracking of patient progress regarding their treatments. Additionally, it provides tools for remote patient evaluation and management, utilizing skin and wound analysis algorithms to measure, segment, and classify images. The platform ensures secure transport of protected health information from the patient's bedside to the provider's desktop. Established in 2014 and based in Baltimore, Maryland, Tissue Analytics operates as a subsidiary of Net Health Systems, Inc. The company has formed a strategic alliance with MolecuLight Inc. to further enhance its offerings.

Keriton LLC is a provider of a pumped breast milk management system specifically designed for neonatal intensive care units (NICUs). Based in Philadelphia, Pennsylvania, the company offers a comprehensive platform that enhances patient safety and streamlines nursing workflows. This system enables healthcare professionals to track milk-bottle inventory, manage feeding orders, and handle first-in-first-out (FIFO) bottle flow, including notifications for expiry dates and misfeed alerts. The platform also facilitates real-time insights into lactating mothers' milk production patterns and includes a media-sharing feature for nurses to communicate with mothers by sharing photos and videos of their babies. With a track record of managing over 1.5 million feeds and preventing nearly 30,000 errors, Keriton's solution aims to improve health outcomes and reduce the cognitive burden on hospital staff. Since its incorporation in 2016, Keriton has been deployed in numerous larger enterprise health systems, demonstrating its effectiveness in enhancing the care provided to infants in NICUs.

Grand Round Table Inc. is a developer of clinical decision support tools aimed at enhancing diagnostic accuracy for healthcare providers. The company's flagship system, Grand Round Table, integrates with electronic health records to assist doctors in diagnosing patients by comparing their cases against a comprehensive database of deidentified health records, case reports, and evidence-based medical literature, including resources from the University of Pennsylvania. This technology enables physicians to access insights from previous cases, facilitating quicker and more informed treatment decisions for complex patients. By streamlining the decision-making process, Grand Round Table helps hospitals and clinics reduce unnecessary tests, ineffective treatments, and consultations, ultimately saving time and costs in patient care. Established in 2011, the company is headquartered in Philadelphia, Pennsylvania.

Tissue Analytics, Inc. is a company that develops a mobile application designed to facilitate the measurement and analysis of chronic wounds, burns, and skin conditions. This innovative solution allows home health agencies, nursing homes, and medical practices to send patient photographs and perform wound analysis. The application automatically generates formatted patient reports and enables tracking of patient progress regarding their treatments. Additionally, it provides tools for remote patient evaluation and management, utilizing skin and wound analysis algorithms to measure, segment, and classify images. The platform ensures secure transport of protected health information from the patient's bedside to the provider's desktop. Established in 2014 and based in Baltimore, Maryland, Tissue Analytics operates as a subsidiary of Net Health Systems, Inc. The company has formed a strategic alliance with MolecuLight Inc. to further enhance its offerings.

Fitly, Inc. develops a mobile web application and countertop device aimed at helping families and children plan, purchase, and prepare healthy meals. The SmartPlate App features food recognition technology, allowing users to choose from specific health goals or create custom plans. When paired with a countertop device, it offers precise image recognition, nutrient analysis, and meal tracking capabilities. The app also provides access to a comprehensive database of packaged and restaurant foods for convenient tracking, along with personalized tips and feedback. Additionally, the SmartPlate TopView device analyzes entire meals and offers guidance on healthy eating habits. Fitly's solutions address various health-related needs, including weight management, endurance, hydration, and portion control. Established in 2011 and headquartered in Philadelphia, Pennsylvania, Fitly is committed to enhancing human health and longevity through innovative nutritional technology.